Le Lézard
Classified in: Health
Subjects: NPT, PER

NSF International Adds Former U.S. Regulator to Medical Device Certification and Training Program


ANN ARBOR, Mich., Jan. 18, 2018 /PRNewswire-USNewswire/ -- NSF International, a global public health organization and leading provider of regulatory compliance, quality systems, analytical testing, education and consulting services for the medical device sector, has appointed U.S. Food and Drug Administration (FDA) veteran Robert Ruff to the post of Executive Director, Medical Device Certification and Training.

Robert Ruff joins NSF International as Executive Director, Medical Device Certification and Training

In his new role, Ruff will provide NSF International's medical device industry clients with expert training and certification services. His primary responsibilities will be to manage key sectors of NSF's global medical device business and to use his expertise and resources in meeting the needs of clients.

"Rob brings the utmost integrity and dedication to NSF International," said Kim Trautman, Executive VP for International Medical Device Services at NSF International. "With his diplomatic manner, extensive knowledge and unique expertise, he accomplishes difficult projects while maintaining collaborative working relationships with colleagues and customers alike. We are thrilled to welcome him aboard."

Ruff brings over 30 years of experience in the medical device and public health sectors to NSF International. After serving in the United States Army, Ruff began his career in the orthopedic industry. From there he went on to a distinguished career at the United States Food and Drug Administration (FDA), where he spent 27 years in various roles, beginning as an investigator for the New Jersey District Office.

At the FDA, Ruff was a member of the Office of Regulatory Affairs (ORA) Medical Device Investigator Certification Board, where he assisted in the development and management of ORA's Level II medical device investigator certification program. Ruff later moved to the FDA's Center for Devices and Radiological Health, where he led an international team of subject matter experts tasked with the development, implementation and maintenance of the Medical Device Single Audit Program (MDSAP).

Throughout his career, Ruff has been extensively published, authoring or co-authoring regulatory audit models ? including Quality System Inspection Technique (QSIT) and the MDSAP Audit Model ? as well as training programs, courses and articles. 

NSF International is a global, independent organization that writes standards, and tests and certifies products for the health sciences, water, food and consumer goods industries to minimize adverse health effects and protect the environment. Founded in 1944, NSF is committed to protecting human health and safety worldwide. With locations in more than 30 countries, NSF International is a Pan American Health Organization/World Health Organization (WHO) Collaborating Center on Food Safety, Water Quality and Indoor Environment.

CONTACT: Thomas Frey, APR
+1 734 214 6242
[email protected]

NSF Logo. (PRNewsFoto/NSF International)

SOURCE NSF International


These press releases may also interest you

at 12:22
Claudia Black, PhD, and Meadows Behavioral Healthcare are proud to announce the release of Undaunted Hope, featuring a foreword by Bessel van der Kolk, MD, author of the New York Times bestseller The Body Keeps the Score....

at 12:20
The "Elastomers: Applications and Global Markets" report has been added to ResearchAndMarkets.com's offering. The Global Elastomers Market was valued at USD 105 Billion in 2023 and is expected to grow to USD 153.5 Billion in 2028, rising at a CAGR...

at 12:07
Getlabs, the nationwide leader in at-home diagnostics collection, has joined forces with Inocras, a leading AI-driven whole genome testing company that empowers patients with critical genetic insights for cancer and rare diseases....

at 12:06
Elegancia Healthcare W.L.L, a subsidiary of Estithmar Holding has entered into a second strategic agreement with...

at 12:05
Molecular Instruments, Inc. announced today that the Patents Court of the High Court of England and Wales has found two patents owned by Advanced Cell Diagnostics, Inc. (a Bio-Techne group company) to be invalid. In a 2022 lawsuit filed in the...

at 12:00
The "Oncology Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Oncology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the oncology deals...



News published on and distributed by: